Portosystemic shunt for portal hypertension after Kasai operation in patients with biliary atresia
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Surgery International
- Vol. 37 (1), 101-107
- https://doi.org/10.1007/s00383-020-04773-2
Abstract
Purpose Many biliary atresia (BA) patients will eventually develop liver failure even after a successful Kasai portoenterostomy. A common complication of long-term BA survivors with their native liver is problematic portal hypertension. The aim of this study was to defend the view that portosystemic shunts can delay or negate the need for transplantation in these children. Methods A retrospective single center review of the efficacy of portosystemic shunts in BA patients after a successful Kasai portoenterostomy was conducted. Results From 1991 to 2017, 11 patients received portosystemic shunts. Median age of Kasai operation was 48 (36-61) days. Shunts were performed at the median age of 6.2 (4.1-6.8) years. Three of these eleven patients required subsequent liver transplantation. OS at 5 and 10 years were 90.9% and 81.8%, respectively. TFS at 5 and 10 years were 90.9% and 72.7%, respectively. Long-term complications included mild encephalopathy in 2 patients, hypersplenism in 3, and cholestasis in 1. Conclusion Portosystemic shunt for the treatment of portal hypertension in carefully selected BA patients is an effective option in delaying or negating the need for liver transplantation.Keywords
This publication has 23 references indexed in Scilit:
- β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2019
- OPTN/SRTR 2017 Annual Data Report: LiverAmerican Journal of Transplantation, 2019
- Late complications of biliary atresia: hepatopulmonary syndrome and portopulmonary hypertensionPediatric Surgery International, 2017
- Incidence of Biliary Atresia and Timing of Hepatoportoenterostomy in the United StatesThe Journal of Pediatrics, 2017
- Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite SymposiumHepatology, 2015
- β-Blocker therapy ameliorates hypersplenism due to portal hypertension in childrenHepatology International, 2014
- Medical and surgical management of portal hypertension in childrenCurrent Treatment Options in Gastroenterology, 2006
- Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosisJournal of Hepatology, 2004
- Portosystemic shunting for paediatric portal hypertensionJournal of Pediatric Surgery, 1997
- Nadolol plus Isosorbide Mononitrate Compared with Sclerotherapy for the Prevention of Variceal RebleedingNew England Journal of Medicine, 1996